Altered ABCC8 and KCNK3 expression has also been reported in IPAH cases without known channel gene variants, suggesting that therapeutic modulation of these genes or channels may be broadly effective for PAH. This evidence concerns the gene KCNK3 and idiopathic pulmonary arterial hypertension.